An international study has estimated that in 2013, there were 14.9 million newly diagnosed cases of cancer and 8.2 million deaths around the world.
An international study published in the JAMA Oncology has estimated that in 2013, there were 14.9 million newly diagnosed cases of cancer and 8.2 million deaths around the world. Called The Global Burden of Disease study, it was conducted by the Global Burden of Disease Cancer Collaboration group. The researchers studied 28 cancers in 188 countries from 1990 to 2013, and found that the percentage of cancer deaths as a part of all deaths incerased from 12% in 1990to 15% in 2013.
While tracheal, bronchus and lung cancer was the leading cause for cancer death in men and women, breast cancer was the leading cause of lost years of healthy life in women and for men it was lung cancer.
Read more on ScienceDaily: http://bit.ly/1eCJIbV
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More